newsfilter
← Latest News
GlobeNewswire·

Parabilis Medicines to Participate in Upcoming November Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (NASDAQ:PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by